View Agent
| Agent Info | |
| Agent: | amuvatinib |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | NA |
| Classification: | a novel orally administered tyrosine kinase inhibitor with in vitro pharmacological activity against mutant KIT, platelet-derived growth factor receptor alpha (PDGFRα), and Rad51 |
| Target: | mutant KIT platelet-derived growth factor receptor alpha (PDGFRα) and Rad51 |
| KEGG Pathway: | NA |
| Wiki Pathway: | NA |